AblationforCardiacArrhythmias near Teaneck, NJ

Biography: Torsten P. Vahl, MD, is the Director of Translational Research and is an attending physician at the Columbia Structural Heart and Valve Center and Columbia Interventional Cardiovascular Care at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. Dr. Vahl is also an Assistant Professor of Medicine at Columbia University Irving Medical Center. Dr. Vahl is board-certified in interventional cardiology, cardiovascular disease, echocardiography, and internal medicine. He specializes in the percutaneous treatment of coronary artery and structural heart disease and cardiac catheterization. His primary focus is on transcatheter aortic valve replacements, transcatheter mitral valve repair and replacement, and left atrial appendage closure. Dr. Vahl is also very involved in many preclinical and first-in-human studies through his association with the Cardiovascular Research Foundation. For example, Dr. Vahl led the ALIGN-AR trial as a national PI, a position that evolved out of his experience with the device from the preclinical studies. Dr. Vahl frequently proctors other interventional cardiologists on TAVR in aortic regurgitation with the Trilogy valve and on TMVR with the Cephea valve. Within the left atrial appendage closure, Dr. Vahl has been very active in developing our intracardiac echo program which allows patients to get this procedure without the need for general anesthesia and TEE. Dr. Vahl attended medical school at the Philipps-Universitt in Marburg, Germany. He did his internal medicine residency and his cardiovascular disease fellowship at Mount Sinai Medical Center in New York City. He also completed a fellowship in both interventional cardiology and structural interventional cardiology, focusing on valvular heart disease, at Columbia University Irving Medical Center.

Biography: Dr. Maurice Rachko, MD is a Cardiology Specialist who practices in New York, NY. He is 62 years old and has been practicing for 38 years. Dr. Maurice Rachko, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Nitin Barman, MD is a Cardiology Specialist who practices in New York, NY. He is 51 years old and has been practicing for 26 years. Dr. Nitin Barman, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: Dr. Gulkarov believes in providing caring and compassionate surgical care, combined with outstanding clinical results.

Biography: Dr. Maria Trivieri, MD is a Cardiology Specialist who practices in New York, NY. She is 52 years old. Dr. Maria Trivieri, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Maya Barghash, MD is an Advanced Heart Failure /amp Transplant Cardiology Specialist who practices in New York, NY. She is 43 years old and has been practicing for 16 years. Dr. Maya Barghash, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Tara Naib, MD is a Cardiology Specialist who practices in New York, NY. She is 45 years old and has been practicing for 18 years. Dr. Tara Naib, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. S. Chiu Wong is a Professor of Medicine of the Greenberg Division of Cardiology in the Department of Medicine of the Weill Medical College of Cornell University. He is the Director of Cardiac Catheterization laboratories at the NewYork-Presbyterian/Weill Cornell Medical Center.Dr. Wong graduated Summa Cum Laude from Columbia College in May 1980 and received his Doctor of Medicine degree from Columbia University, College of Physicians and Surgeons in May 1984. Following his medical internship, residency, and clinical cardiology training at St. Luke's/Roosevelt Medical Center in New York City, he spent one additional stent fellowship year in 1991 under the tutorage of Dr. Richard Schatz at Scripps's Clinic and Research Foundation in La Jolla, California. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.After his medical training, Dr. Wong joined the Cardiology Research Foundation at the Washington Hospital in 1992 and was appointed as Director of Coronary Stent Program in 1993. In 1995, Dr. Wong spearheaded a new cardiac catheterization program at the New York Hospital Medical Center of Queens where he assumed the directorship of coronary interventions. In October 1999, Dr. Wong was recruited to the New York Presbyterian Hospital - Cornell Campus as Director of Cardiac Catheterization Laboratories.Dr. Wong has published extensively in the field of interventional cardiology with special focus on new device angioplasty, saphenous vein graft intervention, cardiogenic shock, and drug eluting stent. His current clinical research interests include novel drug eluting stent designs, access site and PFO closure devices, percutaneous valve repair, and application of stem cell technology in the treatment of myocardial ischemia. In the past five years, Dr. Wong and his colleagues had participated in multiple US pivotal trials that led to the FDA approval of both drug eluting stents for the treatment of symptomatic obstructive coronary artery disease. Dr. Wong has recently served as the national principal investigation in the ECLIPSE trial which evaluated the safety and efficacy of an extra-vascular bio-degradable access site closure device in patients undergoing coronary or peripheral diagnostic/interventional procedures compare to the standard treatment of manual compression.Other exciting areas of ongoing research include percutaneous treatment valvular disease states including mitral regurgitation and aortic stenosis, assessment of novel pharmacologic agents to enhance safety of angioplasty procedures.His clinical research activities have been published in Journal of American College of Cardiology, American Journal of Cardiology, American heart Journal and he has presented his findings at numerous national and international meetings including American Heart Association, American College of Cardiology, Transcatheter Therapeutics, Summer in Seattle, Taiwan Society of Cardiology and Asia Pacific Cardiology Congress. He is recruited to serve as member of the Scientific Advisory Board of multiple major US medical device companies.